| scholarly article | Q13442814 |
| P50 | author | Klaus F. Ley | Q89016809 |
| P2093 | author name string | Jerry L Nadler | |
| Marcia McDuffie | |||
| Margaret A Morris | |||
| P2860 | cites work | Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation | Q24629370 |
| Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice | Q28242854 | ||
| T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow | Q28260601 | ||
| Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration | Q28592508 | ||
| Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists | Q29618071 | ||
| Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 | Q29619644 | ||
| The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice☆ | Q30310830 | ||
| 12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes. | Q30435822 | ||
| Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720. | Q30438675 | ||
| Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs | Q33869799 | ||
| Sphingosine 1-phosphate signalling in mammalian cells | Q33958247 | ||
| T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice | Q36356330 | ||
| Autoimmunity during lymphopenia: a two-hit model | Q36502790 | ||
| Tipping the gatekeeper: S1P regulation of endothelial barrier function | Q36727643 | ||
| Fingolimod: a novel immunosuppressant for multiple sclerosis | Q36929186 | ||
| Can we learn from viruses how to prevent type 1 diabetes?: the role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies | Q37023049 | ||
| The immune modulator FTY720 targets sphingosine 1-phosphate receptors | Q40736684 | ||
| FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homin | Q41042455 | ||
| Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice | Q44260906 | ||
| FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors. | Q44758554 | ||
| The effect of immunomodulators on prevention of autoimmune diabetes is stage dependent: FTY720 prevents diabetes at three different stages in the diabetes-resistant biobreeding rat. | Q44813941 | ||
| NAD+ and ATP released from injured cells induce P2X7-dependent shedding of CD62L and externalization of phosphatidylserine by murine T cells | Q46113851 | ||
| Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry | Q46377682 | ||
| Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720. | Q46478164 | ||
| FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine produ | Q48032286 | ||
| New immunosuppresor strategies in the treatment of murine lupus nephritis. | Q51767729 | ||
| Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. | Q53859655 | ||
| Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice | Q68889645 | ||
| Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells | Q70983849 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 115-128 | |
| P577 | publication date | 2010-08-09 | |
| P1433 | published in | Autoimmunity | Q4826348 |
| P1476 | title | Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells | |
| P478 | volume | 44 |
| Q38021696 | Autoimmunity in 2011. |
| Q30422344 | Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development |
| Q38458872 | FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice |
| Q91565357 | Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome |
| Q37610134 | Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome. |
| Q35551835 | Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors |
| Q40117186 | The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis. |
| Q44146198 | Treatment of autoimmune diabetes in NOD mice by Toll-like receptor 2 tolerance in conjunction with dipeptidyl peptidase 4 inhibition |
Search more.